Published 1990 | Version v1
Report

Synthesis and evaluation of (S)-5-[125I]iodo-2,3-methylenedioxybenzamide

  • 1. Lawrence Berkeley Lab., CA (United States)
  • 2. Univ. of North Carolina, Chapel Hill (United States)

Description

Recent reports have demonstrated that benzamides possessing 2,3-dimethoxy-5-iodo- and 2,3-dihydroxybenzofuran-5-iodo- substitution patterns (termed epidepride and IBF, respectively) are potent dopamine D-2 antagonists. A closely related benzamide ((S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,3-methylenedioxy-5-[I-125]iodo-benzamide, termed IMD) has been synthesized and its activity compared to that of epidepride and IBF. The synthetic pathway and both in vitro and in vivo behavior of the compound are discussed

Additional details

Publishing Information

Imprint Title
Eighth international symposium on radiopharmaceutical chemistry. Abstracts: Final report
Imprint Pagination
458 p.
Journal Page Range
p. 370.
Report number
DOE/ER/60968--1

Conference

Title
8. international symposium on radiopharmaceutical chemistry.
Dates
24-29 Jun 1990.
Place
Princeton, NJ (United States).

Optional Information

Contract/Grant/Project number
Contract AC03-76SF00098
Secondary number(s)
CONF-9006363--Absts.